Nurix Therapeutics, Inc. (NRIX)

Healthcare · Biotechnology · NASDAQ

Nurix Therapeutics, Inc. (NRIX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.65B and a free-cash-flow yield of -11.9%. Over the most recent reported fiscal year, revenue grew 54.0%.

Market cap	$2.65B
Trailing P/E	—
FCF yield	-11.9%
Revenue growth (YoY)	+54.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live NRIX data on Nama Insights →